A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab.
Hideo WadaKatsuya ShirakiTakeshi MatsumotoKei SuzukiYoshiki YamashitaIsao TawaraHideto ShimpoMotomu ShimaokaPublished in: Journal of clinical medicine (2022)
As CWA-TT using a small amount of thrombin (0.5 IU/mL) can reflect thrombin burst and be useful for evaluating FVIII activity, independent of the presence of emicizumab, it is useful for monitoring clotting activity in patients with an anti-FVIII inhibitor treated with emicizumab.
Keyphrases